Laboratory, Epidemiological, and Human Intervention Studies Show That Tea (Camellia sinensis) May Be Useful in the Prevention of Obesity ,

Yang, 2002, Inhibition of carcinogenesis by tea, Annu Rev Pharmacol Toxicol., 42, 25, 10.1146/annurev.pharmtox.42.082101.154309

Balentine, 1997, The chemistry of tea flavonoids, Crit Rev Food Sci Nutr., 37, 693, 10.1080/10408399709527797

Sang, 2004, New dibenzotropolone derivatives characterized from black tea using LC/MS/MS, Bioorg Med Chem., 12, 3009, 10.1016/j.bmc.2004.03.027

Menet, 2004, Analysis of theaflavins and thearubigins from black tea extract by MALDI-TOF mass spectrometry, J Agric Food Chem., 52, 2455, 10.1021/jf035427e

Sang, 2002, Theadibenzotropolone A, a new type pigment from enzymatic oxidation of (-)-epicatechin and (-)-epigallocatechin gallate and characterized from black tea using LC/MS/MS, Tetrahedron Lett., 43, 7129, 10.1016/S0040-4039(02)01707-0

Nakai, 2005, Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro, J Agric Food Chem., 53, 4593, 10.1021/jf047814+

2007-2008

Poirier, 2006, Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss, Arterioscler Thromb Vasc Biol., 26, 968, 10.1161/01.ATV.0000216787.85457.f3

Guh, 2009, The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis, BMC Public Health., 9, 88, 10.1186/1471-2458-9-88

Pischon, 2006, Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC), J Natl Cancer Inst., 98, 920, 10.1093/jnci/djj246

Finkelstein, 2009, Annual medical spending attributable to obesity: payer- and service-specific estimates, Health Aff (Millwood)., 28, w822, 10.1377/hlthaff.28.5.w822

Pories, 2008, Bariatric surgery: risks and rewards, J Clin Endocrinol Metab., 93, S89, 10.1210/jc.2008-1641

Poitou Bernert, 2007, Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment, Diabetes Metab., 33, 13, 10.1016/j.diabet.2006.11.004

Filippatos, 2008, Orlistat-associated adverse effects and drug interactions: a critical review, Drug Saf., 31, 53, 10.2165/00002018-200831010-00005

Lambert, 2005, Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations, Am J Clin Nutr., 81, 284, 10.1093/ajcn/81.1.284S

Yang, 2007, Tea and cancer prevention: molecular mechanisms and human relevance, Toxicol Appl Pharmacol., 224, 265, 10.1016/j.taap.2006.11.024

Higdon, 2003, Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions, Crit Rev Food Sci Nutr., 43, 89, 10.1080/10408690390826464

Wolfram, 2006, Anti-obesity effects of green tea: from bedside to bench, Mol Nutr Food Res., 50, 176, 10.1002/mnfr.200500102

Kao, 2006, Tea, obesity, and diabetes, Mol Nutr Food Res., 50, 188, 10.1002/mnfr.200500109

Moon, 2007, Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity, Chem Biol Interact., 167, 85, 10.1016/j.cbi.2007.02.008

Thielecke, 2009, The potential role of green tea catechins in the prevention of the metabolic syndrome: a review, Phytochemistry., 70, 11, 10.1016/j.phytochem.2008.11.011

Bose, 2008, The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice, J Nutr., 138, 1677, 10.1093/jn/138.9.1677

Wolfram, 2005, TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass, Ann Nutr Metab., 49, 54, 10.1159/000084178

Ito, 2008, Effect of tea catechins on body fat accumulation in rats fed a normal diet, Biomed Res., 29, 27, 10.2220/biomedres.29.27

Yang, 2001, Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet, J Nutr Biochem., 12, 14, 10.1016/S0955-2863(00)00140-6

Kim, 2009, Antilipogenic effect of green tea extract in C57BL/6J-Lep ob/ob mice, Phytother Res., 23, 467, 10.1002/ptr.2647

Bruno, 2008, Green tea extract protects leptin-deficient, spontaenously obese mice from hepatic steatosis and injury, J Nutr., 138, 323, 10.1093/jn/138.2.323

Murase, 2005, Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice, Am J Physiol Regul Integr Comp Physiol., 288, 708, 10.1152/ajpregu.00693.2004

Murase, 2006, Reduction of diet-induced obesity by a combination of tea-catechin intake and regular swimming, Int J Obes (Lond)., 30, 561, 10.1038/sj.ijo.0803135

Wang, 2003, The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase, Biochem Pharmacol., 66, 2039, 10.1016/S0006-2952(03)00585-9

Wang, 2001, Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase, Biochem Biophys Res Commun., 288, 1200, 10.1006/bbrc.2001.5923

Du, 2005, Keemun black tea extract contains potent fatty acid synthase inhibitors and reduces food intake and body weight of rats via oral administration, J Enzyme Inhib Med Chem., 20, 349, 10.1080/14756360500148841

Ikeda, 2005, Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats, J Nutr., 135, 155, 10.1093/jn/135.2.155

Wang, 2006, Green tea catechins inhibit pancreatic phospholipase A (2) and intestinal absorption of lipids in ovariectomized rats, J Nutr Biochem., 17, 492, 10.1016/j.jnutbio.2006.03.004

Ashida, 2004, Anti-obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors, Biofactors., 22, 135, 10.1002/biof.5520220126

Cao, 2007, Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet, J Agric Food Chem., 55, 6372, 10.1021/jf070695o

Hossain, 2002, Polyphenol-induced inhibition of the response of na (+)/glucose cotransporter expressed in Xenopus oocytes, J Agric Food Chem., 50, 5215, 10.1021/jf020252e

Shimizu, 2000, Regulation of intestinal glucose transport by tea catechins, Biofactors., 13, 61, 10.1002/biof.5520130111

Murase, 2002, Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver, Int J Obes Relat Metab Disord., 26, 1459, 10.1038/sj.ijo.0802141

Newmark, 2001, Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice, Carcinogenesis., 22, 1871, 10.1093/carcin/22.11.1871

Wu, 2003, Relationship among habitual tea consumption, percent body fat, and body fat distribution, Obes Res., 11, 1088, 10.1038/oby.2003.149

Hughes, 2008, Higher dietary flavone, flavonol, and catechin intakes are associated with less of an increase in BMI over time in women: a longitudinal analysis from the Netherlands Cohort Study, Am J Clin Nutr., 88, 1341

Nagao, 2005, Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men, Am J Clin Nutr., 81, 122, 10.1093/ajcn/81.1.122

Nagao, 2007, A green tea extract high in catechins reduces body fat and cardiovascular risks in humans, Obesity (Silver Spring)., 15, 1473, 10.1038/oby.2007.176

Nagao, 2009, A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes, Obesity (Silver Spring)., 17, 310, 10.1038/oby.2008.505

Auvichayapat, 2008, Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial, Physiol Behav., 93, 486, 10.1016/j.physbeh.2007.10.009

Diepvens, 2005, Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females, Br J Nutr., 94, 1026, 10.1079/BJN20051580

Hursel, 2009, The effects of green tea on weight loss and weight maintenance: a meta-analysis, Int J Obes (Lond)., 33, 956, 10.1038/ijo.2009.135

Westerterp-Plantenga, 2005, Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation, Obes Res., 13, 1195, 10.1038/oby.2005.142

Maki, 2009, Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults, J Nutr., 139, 264, 10.3945/jn.108.098293

Kohri, 2001, Synthesis of (-)-[4–3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration, J Agric Food Chem., 49, 1042, 10.1021/jf0011236

Chow, 2003, Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals, Clin Cancer Res., 9, 3312

Lambert, 2003, Cancer chemopreventive activity and bioavailability of tea and tea polyphenols, Mutat Res., 523–524, 201, 10.1016/S0027-5107(02)00336-6

Lambert, 2007, Biotransformation of green tea polyphenols and the biological activities of those metabolites, Mol Pharm., 4, 819, 10.1021/mp700075m

Chow, 2001, Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E, Cancer Epidemiol Biomarkers Prev., 10, 53

Lee, 2002, Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability, Cancer Epidemiol Biomarkers Prev., 11, 1025

Chow, 2005, Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals, Clin Cancer Res., 11, 4627, 10.1158/1078-0432.CCR-04-2549

Mulder, 2001, Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry, J Chromatogr B Biomed Sci Appl., 760, 271, 10.1016/S0378-4347(01)00285-7

Ku, 2009, Green tea (-)-epigallocatechin gallate inhibits insulin stimulation of 3T3–L1 preadipocyte mitogenesis via the 67-kDa laminin receptor pathway, Am J Physiol Cell Physiol., 297, C121, 10.1152/ajpcell.00272.2008

Wang, 2009, The effects of green tea (-)-epigallocatechin-3-gallate on reactive oxygen species in 3T3–L1 preadipocytes and adipocytes depend on the glutathione and 67 kDa laminin receptor pathways, Mol Nutr Food Res., 53, 349, 10.1002/mnfr.200800013

Liu, 2006, Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3–L1 adipocytes depends on the ERK pathway, Am J Physiol Endocrinol Metab., 290, E273, 10.1152/ajpendo.00325.2005

Wu, 2005, The apoptotic effect of green tea (-)-epigallocatechin gallate on 3T3–L1 preadipocytes depends on the Cdk2 pathway, J Agric Food Chem., 53, 5695, 10.1021/jf050045p

Cho, 2007, (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3–L1 cells, Am J Physiol Endocrinol Metab., 292, E1166, 10.1152/ajpendo.00436.2006

Yang, 2000, Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion, Life Sci., 66, 411, 10.1016/S0024-3205(99)00607-4

Blumenthal, 2006, Total sales of herbal supplements in United States show steady growth sales in mass market channel show continued decline, HerbalGram., 71, 64

Lambert, 2006, Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues, Drug Metab Dispos., 34, 8, 10.1124/dmd.104.003434

Mazzanti, 2009, Hepatotoxicity from green tea: a review of the literature and two unpublished cases, Eur J Clin Pharmacol., 65, 331, 10.1007/s00228-008-0610-7

Isbrucker, 2006, Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2. Dermal, acute and short-term toxicity studies, Food Chem Toxicol., 44, 636, 10.1016/j.fct.2005.11.003

Galati, 2006, Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins, Free Radic Biol Med., 40, 570, 10.1016/j.freeradbiomed.2005.09.014